Connection
Scott Demarest to Oligonucleotides, Antisense
This is a "connection" page, showing publications Scott Demarest has written about Oligonucleotides, Antisense.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.399 |
|
|
|
-
Aartsma-Rus A, de Gusmao CM, Demarest S, van Roon-Mom W, Graessner H, Bush LW, Kogel C, Yu TW, Synofzik M, Schuele R. Individualized antisense oligonucleotide treatment eligibility of patients living with neurodevelopmental diseases. Cell Rep Med. 2026 Sep 15; 7(9):102989.
Score: 0.233
-
Carvill GL, Matheny T, Hesselberth J, Demarest S. Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology. Neurotherapeutics. 2021 07; 18(3):1500-1514.
Score: 0.166